Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers.


Journal

Clinical pharmacology in drug development
ISSN: 2160-7648
Titre abrégé: Clin Pharmacol Drug Dev
Pays: United States
ID NLM: 101572899

Informations de publication

Date de publication:
05 2022
Historique:
received: 12 08 2021
accepted: 07 12 2021
pubmed: 6 1 2022
medline: 30 4 2022
entrez: 5 1 2022
Statut: ppublish

Résumé

Osteoporosis is a common skeletal disorder, often leading to fragility fracture. Combination therapy with raloxifene, a selective estrogen receptor modulator, and cholecalciferol (vitamin D

Identifiants

pubmed: 34984851
doi: 10.1002/cpdd.1062
pmc: PMC9305550
doi:

Substances chimiques

Cholecalciferol 1C6V77QF41
Raloxifene Hydrochloride 4F86W47BR6

Banques de données

ClinicalTrials.gov
['NCT02654093']

Types de publication

Clinical Trial, Phase I Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

623-631

Informations de copyright

© 2022 The Authors. Clinical Pharmacology in Drug Development published by Wiley Periodicals LLC on behalf of American College of Clinical Pharmacology.

Références

Eur J Obstet Gynecol Reprod Biol. 1999 Jul;85(1):23-9
pubmed: 10428318
Nanomaterials (Basel). 2020 May 31;10(6):
pubmed: 32486508
Clin Pharmacol Drug Dev. 2021 Aug;10(8):850-858
pubmed: 34190419
Breast Cancer Res Treat. 2008 Sep;111(2):377-88
pubmed: 17952589
Drug Metab Dispos. 2018 Dec;46(12):1856-1866
pubmed: 30232176
Am J Manag Care. 2011 May;17 Suppl 6:S164-9
pubmed: 21761955
Transl Res. 2012 Oct;160(4):298-308
pubmed: 22683417
Drugs. 2000 Aug;60(2):379-411
pubmed: 10983739
Clin Ther. 2014 Jan 1;36(1):48-57
pubmed: 24378207
Clin Interv Aging. 2017 Jul 06;12:1065-1077
pubmed: 28740372
Br J Nutr. 2013 Feb 14;109(3):493-502
pubmed: 22583563
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 15;961:62-70
pubmed: 24861873
P T. 2018 Feb;43(2):92-104
pubmed: 29386866
Osteoporos Int. 2014 Oct;25(10):2359-81
pubmed: 25182228
Am Fam Physician. 1999 Sep 15;60(4):1131-9
pubmed: 10507743
QJM. 2005 Sep;98(9):667-76
pubmed: 16006498
Eur J Pediatr. 2012 Oct;171(10):1475-80
pubmed: 22562162
Nat Rev Endocrinol. 2017 Aug;13(8):466-479
pubmed: 28387318
Drug Metab Pharmacokinet. 2015 Dec;30(6):425-33
pubmed: 26611713
J Clin Endocrinol Metab. 2010 Dec;95(12):5443-8
pubmed: 20843951
J Clin Endocrinol Metab. 2002 Aug;87(8):3609-17
pubmed: 12161484
J Pharmacol Exp Ther. 2009 Aug;330(2):389-402
pubmed: 19414624
Mol Neuropsychiatry. 2019 Mar;5(1):28-41
pubmed: 31019916
FASEB J. 2019 Feb;33(2):2084-2094
pubmed: 30222077
J Clin Pharmacol. 2011 Oct;51(10):1439-48
pubmed: 21148044
Pharm Res. 2015 Mar;32(3):1128-40
pubmed: 25319098
Treat Endocrinol. 2005;4(6):371-7; discussion 379
pubmed: 16318403
Am J Health Syst Pharm. 2000 Sep 15;57(18):1669-75; quiz 1676-8
pubmed: 11006795
J Transl Med. 2012 Apr 25;10:76
pubmed: 22533838
Trends Endocrinol Metab. 1999 Oct;10(8):317-319
pubmed: 10481162
J Korean Med Sci. 2014 Jan;29(1):149-52
pubmed: 24431921
Br J Clin Pharmacol. 2009 Apr;67(4):437-44
pubmed: 19371317

Auteurs

Hae Won Lee (HW)

Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.

Woo Youl Kang (WY)

Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.

Wookjae Jung (W)

Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.

Mi-Ri Gwon (MR)

Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.

Kyunghee Cho (K)

Analytical Research Division, Biocore Co. Ltd., Seoul, Republic of Korea.

Backhwan Lee (B)

Department of Clinical Development, Alvogen Korea Co. Ltd., Seoul, Republic of Korea.

Sook Jin Seong (SJ)

Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.

Young-Ran Yoon (YR)

Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Department of Clinical Pharmacology, Kyungpook National University Hospital, Daegu, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH